Vimarsana
Biggest News Aggregation in the World

Brianc Thomas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brianc Thomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brianc Thomas Today - Breaking & Trending Today

How Gene Editing Therapies Could Go Beyond Rare Diseases - Vimarsana News

How Gene Editing Therapies Could Go Beyond Rare Diseases

In the wake of the first CRISPR medicine, scientists are working to develop gene editing therapies for diseases like cystic fibrosis, ALS and cardiovascular disease.

Source: forbes.com
Metagenomi Reports Business Updates and Full Year 2023 Financial Results - Vimarsana News

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024 Proof of...

Metagenomi Reports Business Updates and Full Year 2023 - Vimarsana News

Metagenomi Reports Business Updates and Full Year 2023

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman...

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference - Vimarsana News

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference

EMERYVILLE, Calif., Feb. 29, 2024 -- Metageno­mi, Inc. , a pre­ci­sion genet­ic med­i­cines com­pa­ny com­mit­ted to devel­op­ing cura­tive ther­a­peu­tics for patients using its...

Ionis partners with Metagenomi to add gene editing to its broad technology platform - Vimarsana News

Ionis partners with Metagenomi to add gene editing to its broad technology platform

Collaboration with a leader in gene editing systems is Ionis' latest move to expand and diversify its technology CRISPR-Cas gene editing is a natural extension of Ionis' innovative approach to... | November 14, 2022